FTC Chief Says Generic-Drug Deals Cost Public $3.5B
Consumers could save more than $3.5 billion a year if pharmaceutical companies were prevented from colluding with their generic competitors to keep low-cost generic drugs off the market, Federal Trade Commission...To view the full article, register now.
Already a subscriber? Click here to view full article